Cargando…

In Vitro Apoptotic Effects of Farnesyltransferase blockade in Acute Myeloid Leukemia Cells

Farnesyltransferase inhibitors (FTIs) are a class of oral anti-cancer drugs currently tested in phase I-II clinical trials for treatment of hematological malignancies. The in vitro effects of various FTIs (alpha-hydroxyfarnesylphosphonic acid, manumycin-A and SCH66336) were tested on CD34(+) KG1a ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giudice, V, Ricci, P, Marino, L, Rocco, M, Villani, G, Langella, M, Manente, L, Seneca, E, Ferrara, I, Pezzullo, L, Serio, B, Selleri, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università di Salerno 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120747/ https://www.ncbi.nlm.nih.gov/pubmed/27896224

Ejemplares similares

Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment
por: Rosamilio, R., et al.
Publicado: (2016)

Kaposi’s sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy
por: D’Addona, Matteo, et al.
Publicado: (2022)

Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient
por: Serio, Bianca, et al.
Publicado: (2022)

Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia
por: Giudice, Valentina, et al.
Publicado: (2016)

Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience
por: Giudice, Valentina, et al.
Publicado: (2022)

WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Giudice, Valentina, et al.
Publicado: (2021)

Accelerated Bone Mass Senescence After Hematopoietic Stem Cell Transplantation
por: Serio, B, et al.
Publicado: (2013)

OPSI threat in hematological patients
por: Serio, B, et al.
Publicado: ( 201)

Engineering Protein Farnesyltransferase for Enzymatic Protein Labeling Applications
por: Dozier, Jonathan K., et al.
Publicado: (2014)

Enhanced Antiproliferative and Apoptotic Response of HT-29 Adenocarcinoma Cells to Combination of Photoactivated Hypericin and Farnesyltransferase Inhibitor Manumycin A
por: Sačková, Veronika, et al.
Publicado: (2011)

Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase
por: Weber, Lea, et al.
Publicado: (2021)

Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review
por: D’Addona, Matteo, et al.
Publicado: (2022)

MALDI-MS Analysis of Peptide Libraries Expands the Scope of Substrates for Farnesyltransferase
por: Schey, Garrett L., et al.
Publicado: (2021)

Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor
por: DeGeorge, Katharine C, et al.
Publicado: (2008)

Peptidomimetic blockade of MYB in acute myeloid leukemia
por: Ramaswamy, Kavitha, et al.
Publicado: (2018)

New targets for therapy in breast cancer: Farnesyltransferase inhibitors
por: Head, Julia, et al.
Publicado: (2004)

Effect of farnesyltransferase inhibitor on the function of mitochondria of Plasmodium falciparum
por: Ha, Young Ran, et al.
Publicado: (2012)

An overview on natural farnesyltransferase inhibitors for efficient cancer therapy
por: Dai, Xiaohan, et al.
Publicado: (2020)

Effect of farnesyltransferase inhibitors on SARS-CoV-2
por: Weber, Lea, et al.
Publicado: (2023)

Analyzing the postulated inhibitory effect of Manumycin A on farnesyltransferase
por: Hagemann, Anna, et al.
Publicado: (2022)

Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia
por: Giudice, Valentina, et al.
Publicado: (2022)

Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni
por: Probst, Alexandra, et al.
Publicado: (2019)

In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida
por: Qiao, Jianjun, et al.
Publicado: (2013)

Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria
por: Yang, Shao H., et al.
Publicado: (2010)

Effect of Farnesyltransferase Inhibitor R115777 on Mitochondria of Plasmodium falciparum
por: Ha, Young Ran, et al.
Publicado: (2015)

Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments
por: Ha, Nguyen Thi, et al.
Publicado: (2020)

Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells
por: Bontempo, Paola, et al.
Publicado: (2009)

Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells
por: Ma, Yufang, et al.
Publicado: (2017)

New targeted therapies in myelodysplastic syndrome: the role of farnesyltransferase and proteasome inhibitors
por: Gonçalves, A Cristina, et al.
Publicado: (2010)

A Farnesyltransferase Acts to Inhibit Ectopic Neurite Formation in C. elegans
por: Carr, David, et al.
Publicado: (2016)

Phenothiazine- and Carbazole-Cyanochalcones as Dual Inhibitors of Tubulin Polymerization and Human Farnesyltransferase
por: Zubaș, Andreea, et al.
Publicado: (2023)

Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques
por: Al-Balas, Qosay A., et al.
Publicado: (2013)

Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia
por: Laidlaw, Kamilla M.E., et al.
Publicado: (2016)

BAG1: The Guardian of Anti-Apoptotic Proteins in Acute Myeloid Leukemia
por: Aveic, Sanja, et al.
Publicado: (2011)

Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia
por: Zhou, Cheng, et al.
Publicado: (2022)

Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors
por: Nigam, Aradhya, et al.
Publicado: (2023)

P1544: IMPACT OF SARS-COV 2 INFECTION, IN TREATED NHL-B AND HD, AFTER VACCINATION AND PREVENTIVE THERAPY WITH ANTIBODIES: OUR EXPERIENCE
por: Pezzullo, Luca, et al.
Publicado: (2023)

Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
por: Gajewski, Thomas F, et al.
Publicado: (2012)

Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia
por: Zee, Barry M., et al.
Publicado: (2021)

Preventing farnesylation of the dynein adaptor Spindly contributes to the mitotic defects caused by farnesyltransferase inhibitors
por: Holland, Andrew J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_541g6mnjad0d1bc8gs9sfmjj2m